Independent Pharmacy Cooperative

Independent Pharmacy Cooperative filed a Q3 report for Independent Pharmacy Cooperative on October 16, 2025.

Lobbying for Independent Pharmacy Cooperative · National GPO and drug distribution services for independent pharmacies.

As filed: INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE.

All filings by Independent Pharmacy Cooperative · Everything Independent Pharmacy Cooperative has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Expenses

$40,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Wisconsin

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Pharmacy

IPC supports Protecting Pharmacies in Medicaid Act (S.927). IPC supports PBM Reform Act of 2025 (HR 4317). IPC supports Patients Before Middlemen Act (S 882). IPC supports The Ensuring Community Access to Pharmacist Services Act of 2025 (ECAPS). CMS Implementation of drug provisions of the IRA 2022-including the drug negotiation provision with changes and prescription drug co-pay spread option. IPC supports the removal of the mandatory NADAC reporting requirement in the OBBB without an adequate and defined corresponding professional dispensing fee. IPC supports the Rural Health Transformation Program.

Bills named in this filing 2

S. 927
Protecting Pharmacies in Medicaid Act
H.R. 4317
PBM Reform Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.